162 related articles for article (PubMed ID: 37642765)
21. NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.
Miftah H; Naji O; Ssi SA; Ghouzlani A; Lakhdar A; Badou A
Front Immunol; 2023; 14():1139268. PubMed ID: 37575237
[TBL] [Abstract][Full Text] [Related]
22. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Ma K; Chen S; Chen X; Yang C; Yang J
World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.
Liu Z; Cheng X; Lin S; Han Z; Jin H; Luan Z; Li P; Liang W; Qian R; Gao Y
Cell Mol Neurobiol; 2023 Jan; 43(1):409-422. PubMed ID: 35106666
[TBL] [Abstract][Full Text] [Related]
24. Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy.
Chen S; Zhang S; Feng W; Li J; Yuan Y; Li W; Wang Z; Yang Y; Liu Y
Front Pharmacol; 2022; 13():1072253. PubMed ID: 36467068
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial Dysfunction and the Glycolytic Switch Induced by Caveolin-1 Phosphorylation Promote Cancer Cell Migration, Invasion, and Metastasis.
Díaz-Valdivia N; Simón L; Díaz J; Martinez-Meza S; Contreras P; Burgos-Ravanal R; Pérez VI; Frei B; Leyton L; Quest AFG
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740528
[TBL] [Abstract][Full Text] [Related]
26. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.
Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161
[TBL] [Abstract][Full Text] [Related]
27. Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma.
Zhang S; Chen S; Wang Z; Li J; Yuan Y; Feng W; Li W; Chen M; Liu Y
Front Pharmacol; 2022; 13():1061597. PubMed ID: 36386216
[TBL] [Abstract][Full Text] [Related]
28. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
29. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
[TBL] [Abstract][Full Text] [Related]
30. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
31. Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.
Yang P; Wang K; Zhang C; Wang Z; Liu Q; Wang J; Jiang T; Shan X
Cancer Immunol Immunother; 2021 Sep; 70(9):2589-2600. PubMed ID: 33576871
[TBL] [Abstract][Full Text] [Related]
32. Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.
Chen S; Zhang S; Wang Z; Li J; Yuan Y; Li T; Zuo M; Feng W; Li W; Chen M; Liu Y
Front Pharmacol; 2022; 13():1038272. PubMed ID: 36438805
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of m
Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
Front Immunol; 2022; 13():955848. PubMed ID: 36203569
[TBL] [Abstract][Full Text] [Related]
34. Integration of clinical and spatial data to explore lipid metabolism-related genes for predicting prognosis and immune microenvironment in gliomas.
Yu Z; Zhou Y; Li Y; Dong Z
Funct Integr Genomics; 2023 Mar; 23(2):82. PubMed ID: 36929451
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance and therapeutic implications of Caveolin-1 in gastrointestinal tract malignancies.
Kamposioras K; Vassilakopoulou M; Anthoney A; Bariuoso J; Mauri D; Mansoor W; Papadopoulos V; Dimas K
Pharmacol Ther; 2022 May; 233():108028. PubMed ID: 34755606
[TBL] [Abstract][Full Text] [Related]
36. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
[TBL] [Abstract][Full Text] [Related]
37. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
38. ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas.
Li S; Zhang N; Liu S; Zhang H; Liu J; Qi Y; Zhang Q; Li X
Front Oncol; 2022; 12():844144. PubMed ID: 35371978
[TBL] [Abstract][Full Text] [Related]
39. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
40. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
